Register for the 3rd Annual Gene Therapy Immunogenicity Summit Below!
Registering online is quick and easy. Simply click the appropriate button below to start the registration process:
All prices shown in USD
Bring Your Team!
10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5 or more delegates
*To qualify for group discounts, all passes must be purchased at the same time. Group discounts will automatically be applied at checkout if registering online. A customer service representative will be in touch within one working day to confirm your registration. Full T&Cs apply.
Drug Developer Pricing
To Save Up To $700
Conference + Workshop Day
$3,196Conference Only
$2,299
| Drug Developer Pricing | Register & Pay by Friday, July 15 To Save Up To $700 | On The Door |
| Conference + Workshop Day | $3,196 (Save $700) | $3,896 |
| Conference Only | $2,299 (Save $700) | $2,999 |
*To be eligible for the drug developer price, the group or individual must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services
Academic Pricing
To Save Up To $700
Conference + Workshop Day
$2,496Conference Only
$1,899
| Vendor Pricing | Register & Pay by Friday, July 15 To Save Up To $700 | On The Door |
| Conference + Workshop Day | $2,496 (Save $700) | $3,196 |
| Conference Only | $1,899 (Save $700) | $2,599 |
*To be eligible for the drug developer price, the group or individual must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services
Vendor Pricing
To Save Up To $700
Conference + Workshop Day
$4,196Conference Only
$3,299
| Vendor Pricing | Register & Pay by Friday, July 15 To Save Up To $700 | On The Door |
| Conference + Workshop Day | $4,196 (Save $700) | $4,896 |
| Conference Only | $3,299 (Save $700) | $3,999 |
*To be eligible for the drug developer price, the group or individual must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services
“Very useful review of the current state of the field”
Director Clinical Science,
Vertex Pharma